nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—CES1—Ciclesonide—asthma	0.315	0.51	CbGbCtD
Dabigatran etexilate—UGT1A9—Zileuton—asthma	0.158	0.256	CbGbCtD
Dabigatran etexilate—ABCB1—Fluticasone furoate—asthma	0.038	0.0616	CbGbCtD
Dabigatran etexilate—ABCB1—Indacaterol—asthma	0.031	0.0502	CbGbCtD
Dabigatran etexilate—ABCB1—Loratadine—asthma	0.0165	0.0268	CbGbCtD
Dabigatran etexilate—ABCB1—Methylprednisolone—asthma	0.0151	0.0245	CbGbCtD
Dabigatran etexilate—ABCB1—Betamethasone—asthma	0.00984	0.0159	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisolone—asthma	0.00971	0.0157	CbGbCtD
Dabigatran etexilate—ABCB1—Hydrocortisone—asthma	0.00921	0.0149	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisone—asthma	0.00917	0.0149	CbGbCtD
Dabigatran etexilate—ABCB1—Dexamethasone—asthma	0.00572	0.00927	CbGbCtD
Dabigatran etexilate—CES2—respiratory system—asthma	0.00256	0.0623	CbGeAlD
Dabigatran etexilate—F2—respiratory system—asthma	0.00229	0.0559	CbGeAlD
Dabigatran etexilate—CES2—adrenal cortex—asthma	0.00215	0.0523	CbGeAlD
Dabigatran etexilate—CES1—respiratory system—asthma	0.00211	0.0513	CbGeAlD
Dabigatran etexilate—CES2—bronchus—asthma	0.0021	0.0513	CbGeAlD
Dabigatran etexilate—CES2—smooth muscle tissue—asthma	0.00206	0.0502	CbGeAlD
Dabigatran etexilate—CES2—cardiovascular system—asthma	0.00196	0.0477	CbGeAlD
Dabigatran etexilate—NQO2—adrenal cortex—asthma	0.00192	0.0467	CbGeAlD
Dabigatran etexilate—F2—epithelium—asthma	0.00192	0.0467	CbGeAlD
Dabigatran etexilate—CES2—trachea—asthma	0.00189	0.0461	CbGeAlD
Dabigatran etexilate—NQO2—bronchus—asthma	0.00188	0.0458	CbGeAlD
Dabigatran etexilate—F2—cardiovascular system—asthma	0.00176	0.0428	CbGeAlD
Dabigatran etexilate—NQO2—trachea—asthma	0.00169	0.0412	CbGeAlD
Dabigatran etexilate—CES1—cardiovascular system—asthma	0.00161	0.0393	CbGeAlD
Dabigatran etexilate—CES2—adrenal gland—asthma	0.00155	0.0378	CbGeAlD
Dabigatran etexilate—F2—adrenal gland—asthma	0.00139	0.0339	CbGeAlD
Dabigatran etexilate—NQO2—adrenal gland—asthma	0.00138	0.0337	CbGeAlD
Dabigatran etexilate—CES2—lung—asthma	0.00136	0.0331	CbGeAlD
Dabigatran etexilate—CES1—adrenal gland—asthma	0.00128	0.0311	CbGeAlD
Dabigatran etexilate—F2—lung—asthma	0.00122	0.0297	CbGeAlD
Dabigatran etexilate—NQO2—lung—asthma	0.00121	0.0296	CbGeAlD
Dabigatran etexilate—CES1—lung—asthma	0.00112	0.0273	CbGeAlD
Dabigatran etexilate—ABCB1—respiratory system—asthma	0.000493	0.012	CbGeAlD
Dabigatran etexilate—ABCB1—adrenal cortex—asthma	0.000414	0.0101	CbGeAlD
Dabigatran etexilate—ABCB1—epithelium—asthma	0.000412	0.01	CbGeAlD
Dabigatran etexilate—ABCB1—cardiovascular system—asthma	0.000378	0.00921	CbGeAlD
Dabigatran etexilate—ABCB1—trachea—asthma	0.000365	0.00889	CbGeAlD
Dabigatran etexilate—ABCB1—adrenal gland—asthma	0.000299	0.00728	CbGeAlD
Dabigatran etexilate—ABCB1—lung—asthma	0.000262	0.00638	CbGeAlD
Dabigatran etexilate—Asthenia—Montelukast—asthma	9.87e-05	0.000399	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Triamcinolone—asthma	9.85e-05	0.000398	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methylprednisolone—asthma	9.83e-05	0.000398	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Dexamethasone—asthma	9.81e-05	0.000397	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Betamethasone—asthma	9.81e-05	0.000397	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Salbutamol—asthma	9.78e-05	0.000395	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Betamethasone—asthma	9.76e-05	0.000395	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Dexamethasone—asthma	9.76e-05	0.000395	CcSEcCtD
Dabigatran etexilate—Pruritus—Montelukast—asthma	9.74e-05	0.000394	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Methylprednisolone—asthma	9.66e-05	0.000391	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Arformoterol—asthma	9.61e-05	0.000389	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Formoterol—asthma	9.61e-05	0.000389	CcSEcCtD
Dabigatran etexilate—Nausea—Flunisolide—asthma	9.59e-05	0.000388	CcSEcCtD
Dabigatran etexilate—Asthenia—Salbutamol—asthma	9.52e-05	0.000385	CcSEcCtD
Dabigatran etexilate—Vomiting—Mometasone—asthma	9.52e-05	0.000385	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Budesonide—asthma	9.47e-05	0.000383	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Hydrocortisone—asthma	9.45e-05	0.000382	CcSEcCtD
Dabigatran etexilate—Rash—Mometasone—asthma	9.44e-05	0.000382	CcSEcCtD
Dabigatran etexilate—Dermatitis—Mometasone—asthma	9.43e-05	0.000381	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Montelukast—asthma	9.42e-05	0.000381	CcSEcCtD
Dabigatran etexilate—Pruritus—Salbutamol—asthma	9.39e-05	0.00038	CcSEcCtD
Dabigatran etexilate—Headache—Mometasone—asthma	9.38e-05	0.000379	CcSEcCtD
Dabigatran etexilate—Dizziness—Formoterol—asthma	9.29e-05	0.000376	CcSEcCtD
Dabigatran etexilate—Dizziness—Arformoterol—asthma	9.29e-05	0.000376	CcSEcCtD
Dabigatran etexilate—Asthenia—Budesonide—asthma	9.22e-05	0.000373	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methylprednisolone—asthma	9.12e-05	0.000369	CcSEcCtD
Dabigatran etexilate—Malnutrition—Hydrocortisone—asthma	9.11e-05	0.000368	CcSEcCtD
Dabigatran etexilate—Dizziness—Montelukast—asthma	9.1e-05	0.000368	CcSEcCtD
Dabigatran etexilate—Pruritus—Budesonide—asthma	9.09e-05	0.000368	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Salbutamol—asthma	9.08e-05	0.000367	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Dexamethasone—asthma	8.98e-05	0.000363	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Betamethasone—asthma	8.98e-05	0.000363	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Betamethasone—asthma	8.94e-05	0.000362	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Dexamethasone—asthma	8.94e-05	0.000362	CcSEcCtD
Dabigatran etexilate—Vomiting—Formoterol—asthma	8.93e-05	0.000361	CcSEcCtD
Dabigatran etexilate—Vomiting—Arformoterol—asthma	8.93e-05	0.000361	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methylprednisolone—asthma	8.92e-05	0.000361	CcSEcCtD
Dabigatran etexilate—Nausea—Mometasone—asthma	8.89e-05	0.00036	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methylprednisolone—asthma	8.88e-05	0.000359	CcSEcCtD
Dabigatran etexilate—Rash—Arformoterol—asthma	8.86e-05	0.000358	CcSEcCtD
Dabigatran etexilate—Rash—Formoterol—asthma	8.86e-05	0.000358	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methylprednisolone—asthma	8.86e-05	0.000358	CcSEcCtD
Dabigatran etexilate—Dermatitis—Arformoterol—asthma	8.85e-05	0.000358	CcSEcCtD
Dabigatran etexilate—Dermatitis—Formoterol—asthma	8.85e-05	0.000358	CcSEcCtD
Dabigatran etexilate—Headache—Arformoterol—asthma	8.8e-05	0.000356	CcSEcCtD
Dabigatran etexilate—Headache—Formoterol—asthma	8.8e-05	0.000356	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Budesonide—asthma	8.79e-05	0.000356	CcSEcCtD
Dabigatran etexilate—Dizziness—Salbutamol—asthma	8.77e-05	0.000355	CcSEcCtD
Dabigatran etexilate—Vomiting—Montelukast—asthma	8.75e-05	0.000354	CcSEcCtD
Dabigatran etexilate—Rash—Montelukast—asthma	8.68e-05	0.000351	CcSEcCtD
Dabigatran etexilate—Dermatitis—Montelukast—asthma	8.67e-05	0.000351	CcSEcCtD
Dabigatran etexilate—Headache—Montelukast—asthma	8.62e-05	0.000349	CcSEcCtD
Dabigatran etexilate—Malnutrition—Methylprednisolone—asthma	8.56e-05	0.000346	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisone—asthma	8.55e-05	0.000346	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisolone—asthma	8.52e-05	0.000345	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Prednisone—asthma	8.5e-05	0.000344	CcSEcCtD
Dabigatran etexilate—Dizziness—Budesonide—asthma	8.5e-05	0.000344	CcSEcCtD
Dabigatran etexilate—Vomiting—Salbutamol—asthma	8.44e-05	0.000341	CcSEcCtD
Dabigatran etexilate—Rash—Salbutamol—asthma	8.37e-05	0.000338	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisolone—asthma	8.36e-05	0.000338	CcSEcCtD
Dabigatran etexilate—Dermatitis—Salbutamol—asthma	8.36e-05	0.000338	CcSEcCtD
Dabigatran etexilate—Nausea—Formoterol—asthma	8.35e-05	0.000338	CcSEcCtD
Dabigatran etexilate—Nausea—Arformoterol—asthma	8.35e-05	0.000338	CcSEcCtD
Dabigatran etexilate—Angioedema—Hydrocortisone—asthma	8.32e-05	0.000337	CcSEcCtD
Dabigatran etexilate—Headache—Salbutamol—asthma	8.31e-05	0.000336	CcSEcCtD
Dabigatran etexilate—Back pain—Triamcinolone—asthma	8.29e-05	0.000336	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisolone—asthma	8.2e-05	0.000332	CcSEcCtD
Dabigatran etexilate—Nausea—Montelukast—asthma	8.18e-05	0.000331	CcSEcCtD
Dabigatran etexilate—Vomiting—Budesonide—asthma	8.17e-05	0.000331	CcSEcCtD
Dabigatran etexilate—Syncope—Hydrocortisone—asthma	8.17e-05	0.00033	CcSEcCtD
Dabigatran etexilate—Angiopathy—Dexamethasone—asthma	8.11e-05	0.000328	CcSEcCtD
Dabigatran etexilate—Angiopathy—Betamethasone—asthma	8.11e-05	0.000328	CcSEcCtD
Dabigatran etexilate—Rash—Budesonide—asthma	8.1e-05	0.000328	CcSEcCtD
Dabigatran etexilate—Dermatitis—Budesonide—asthma	8.1e-05	0.000327	CcSEcCtD
Dabigatran etexilate—Headache—Budesonide—asthma	8.05e-05	0.000326	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisolone—asthma	8.05e-05	0.000326	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Hydrocortisone—asthma	8e-05	0.000324	CcSEcCtD
Dabigatran etexilate—Nausea—Salbutamol—asthma	7.88e-05	0.000319	CcSEcCtD
Dabigatran etexilate—Hypertension—Hydrocortisone—asthma	7.86e-05	0.000318	CcSEcCtD
Dabigatran etexilate—Angioedema—Triamcinolone—asthma	7.84e-05	0.000317	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisone—asthma	7.82e-05	0.000316	CcSEcCtD
Dabigatran etexilate—Angioedema—Methylprednisolone—asthma	7.82e-05	0.000316	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisone—asthma	7.78e-05	0.000315	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	7.7e-05	0.000311	CcSEcCtD
Dabigatran etexilate—Syncope—Triamcinolone—asthma	7.69e-05	0.000311	CcSEcCtD
Dabigatran etexilate—Syncope—Methylprednisolone—asthma	7.67e-05	0.00031	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Prednisone—asthma	7.65e-05	0.000309	CcSEcCtD
Dabigatran etexilate—Nausea—Budesonide—asthma	7.63e-05	0.000309	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisolone—asthma	7.61e-05	0.000308	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Triamcinolone—asthma	7.54e-05	0.000305	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Methylprednisolone—asthma	7.52e-05	0.000304	CcSEcCtD
Dabigatran etexilate—Shock—Prednisolone—asthma	7.49e-05	0.000303	CcSEcCtD
Dabigatran etexilate—Cough—Triamcinolone—asthma	7.48e-05	0.000303	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Hydrocortisone—asthma	7.43e-05	0.000301	CcSEcCtD
Dabigatran etexilate—Hypertension—Triamcinolone—asthma	7.4e-05	0.000299	CcSEcCtD
Dabigatran etexilate—Hypertension—Methylprednisolone—asthma	7.39e-05	0.000299	CcSEcCtD
Dabigatran etexilate—Infection—Hydrocortisone—asthma	7.38e-05	0.000299	CcSEcCtD
Dabigatran etexilate—Shock—Hydrocortisone—asthma	7.31e-05	0.000296	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Hydrocortisone—asthma	7.29e-05	0.000295	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methylprednisolone—asthma	7.28e-05	0.000295	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	7.23e-05	0.000293	CcSEcCtD
Dabigatran etexilate—Skin disorder—Hydrocortisone—asthma	7.22e-05	0.000292	CcSEcCtD
Dabigatran etexilate—Angioedema—Dexamethasone—asthma	7.11e-05	0.000288	CcSEcCtD
Dabigatran etexilate—Angioedema—Betamethasone—asthma	7.11e-05	0.000288	CcSEcCtD
Dabigatran etexilate—Angiopathy—Prednisone—asthma	7.06e-05	0.000286	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Prednisone—asthma	7.03e-05	0.000284	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Triamcinolone—asthma	7e-05	0.000283	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Methylprednisolone—asthma	6.98e-05	0.000282	CcSEcCtD
Dabigatran etexilate—Syncope—Dexamethasone—asthma	6.98e-05	0.000282	CcSEcCtD
Dabigatran etexilate—Syncope—Betamethasone—asthma	6.98e-05	0.000282	CcSEcCtD
Dabigatran etexilate—Infection—Triamcinolone—asthma	6.95e-05	0.000281	CcSEcCtD
Dabigatran etexilate—Hypotension—Hydrocortisone—asthma	6.94e-05	0.000281	CcSEcCtD
Dabigatran etexilate—Infection—Methylprednisolone—asthma	6.94e-05	0.000281	CcSEcCtD
Dabigatran etexilate—Shock—Triamcinolone—asthma	6.89e-05	0.000279	CcSEcCtD
Dabigatran etexilate—Shock—Methylprednisolone—asthma	6.87e-05	0.000278	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methylprednisolone—asthma	6.85e-05	0.000277	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Betamethasone—asthma	6.84e-05	0.000277	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Dexamethasone—asthma	6.84e-05	0.000277	CcSEcCtD
Dabigatran etexilate—Skin disorder—Methylprednisolone—asthma	6.78e-05	0.000274	CcSEcCtD
Dabigatran etexilate—Malnutrition—Prednisone—asthma	6.78e-05	0.000274	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Hydrocortisone—asthma	6.77e-05	0.000274	CcSEcCtD
Dabigatran etexilate—Hypertension—Dexamethasone—asthma	6.72e-05	0.000272	CcSEcCtD
Dabigatran etexilate—Hypertension—Betamethasone—asthma	6.72e-05	0.000272	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Hydrocortisone—asthma	6.54e-05	0.000265	CcSEcCtD
Dabigatran etexilate—Hypotension—Methylprednisolone—asthma	6.52e-05	0.000264	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Hydrocortisone—asthma	6.42e-05	0.00026	CcSEcCtD
Dabigatran etexilate—Fatigue—Hydrocortisone—asthma	6.41e-05	0.000259	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Triamcinolone—asthma	6.38e-05	0.000258	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methylprednisolone—asthma	6.36e-05	0.000257	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Betamethasone—asthma	6.35e-05	0.000257	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Dexamethasone—asthma	6.35e-05	0.000257	CcSEcCtD
Dabigatran etexilate—Infection—Dexamethasone—asthma	6.31e-05	0.000255	CcSEcCtD
Dabigatran etexilate—Infection—Betamethasone—asthma	6.31e-05	0.000255	CcSEcCtD
Dabigatran etexilate—Anaemia—Prednisone—asthma	6.26e-05	0.000253	CcSEcCtD
Dabigatran etexilate—Shock—Dexamethasone—asthma	6.25e-05	0.000253	CcSEcCtD
Dabigatran etexilate—Shock—Betamethasone—asthma	6.25e-05	0.000253	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Triamcinolone—asthma	6.24e-05	0.000252	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Betamethasone—asthma	6.23e-05	0.000252	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Dexamethasone—asthma	6.23e-05	0.000252	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Betamethasone—asthma	6.22e-05	0.000251	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Dexamethasone—asthma	6.22e-05	0.000251	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisone—asthma	6.19e-05	0.00025	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Triamcinolone—asthma	6.16e-05	0.000249	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methylprednisolone—asthma	6.15e-05	0.000249	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Hydrocortisone—asthma	6.08e-05	0.000246	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisone—asthma	6.08e-05	0.000246	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisolone—asthma	6.05e-05	0.000245	CcSEcCtD
Dabigatran etexilate—Fatigue—Triamcinolone—asthma	6.03e-05	0.000244	CcSEcCtD
Dabigatran etexilate—Fatigue—Methylprednisolone—asthma	6.02e-05	0.000244	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisone—asthma	5.96e-05	0.000241	CcSEcCtD
Dabigatran etexilate—Hypotension—Dexamethasone—asthma	5.93e-05	0.00024	CcSEcCtD
Dabigatran etexilate—Hypotension—Betamethasone—asthma	5.93e-05	0.00024	CcSEcCtD
Dabigatran etexilate—Urticaria—Hydrocortisone—asthma	5.9e-05	0.000239	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Hydrocortisone—asthma	5.88e-05	0.000238	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisone—asthma	5.85e-05	0.000237	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Dexamethasone—asthma	5.79e-05	0.000234	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Betamethasone—asthma	5.79e-05	0.000234	CcSEcCtD
Dabigatran etexilate—Arthralgia—Prednisone—asthma	5.77e-05	0.000233	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	5.73e-05	0.000232	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methylprednisolone—asthma	5.71e-05	0.000231	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Prednisolone—asthma	5.61e-05	0.000227	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Dexamethasone—asthma	5.59e-05	0.000226	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Betamethasone—asthma	5.59e-05	0.000226	CcSEcCtD
Dabigatran etexilate—Urticaria—Triamcinolone—asthma	5.56e-05	0.000225	CcSEcCtD
Dabigatran etexilate—Urticaria—Methylprednisolone—asthma	5.55e-05	0.000224	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisone—asthma	5.53e-05	0.000224	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Methylprednisolone—asthma	5.52e-05	0.000223	CcSEcCtD
Dabigatran etexilate—Infection—Prednisone—asthma	5.49e-05	0.000222	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Dexamethasone—asthma	5.48e-05	0.000222	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Betamethasone—asthma	5.48e-05	0.000222	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Hydrocortisone—asthma	5.48e-05	0.000222	CcSEcCtD
Dabigatran etexilate—Fatigue—Betamethasone—asthma	5.47e-05	0.000221	CcSEcCtD
Dabigatran etexilate—Fatigue—Dexamethasone—asthma	5.47e-05	0.000221	CcSEcCtD
Dabigatran etexilate—Shock—Prednisone—asthma	5.44e-05	0.00022	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Prednisone—asthma	5.42e-05	0.000219	CcSEcCtD
Dabigatran etexilate—Skin disorder—Prednisone—asthma	5.37e-05	0.000217	CcSEcCtD
Dabigatran etexilate—Asthenia—Hydrocortisone—asthma	5.33e-05	0.000216	CcSEcCtD
Dabigatran etexilate—Pruritus—Hydrocortisone—asthma	5.26e-05	0.000213	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Betamethasone—asthma	5.19e-05	0.00021	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Dexamethasone—asthma	5.19e-05	0.00021	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Triamcinolone—asthma	5.16e-05	0.000209	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Methylprednisolone—asthma	5.14e-05	0.000208	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Hydrocortisone—asthma	5.09e-05	0.000206	CcSEcCtD
Dabigatran etexilate—Urticaria—Dexamethasone—asthma	5.04e-05	0.000204	CcSEcCtD
Dabigatran etexilate—Urticaria—Betamethasone—asthma	5.04e-05	0.000204	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Prednisone—asthma	5.04e-05	0.000204	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisolone—asthma	5.03e-05	0.000204	CcSEcCtD
Dabigatran etexilate—Asthenia—Triamcinolone—asthma	5.02e-05	0.000203	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dexamethasone—asthma	5.02e-05	0.000203	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Betamethasone—asthma	5.02e-05	0.000203	CcSEcCtD
Dabigatran etexilate—Asthenia—Methylprednisolone—asthma	5.01e-05	0.000203	CcSEcCtD
Dabigatran etexilate—Pruritus—Triamcinolone—asthma	4.95e-05	0.0002	CcSEcCtD
Dabigatran etexilate—Pruritus—Methylprednisolone—asthma	4.94e-05	0.0002	CcSEcCtD
Dabigatran etexilate—Dizziness—Hydrocortisone—asthma	4.91e-05	0.000199	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Prednisone—asthma	4.87e-05	0.000197	CcSEcCtD
Dabigatran etexilate—Rash—Prednisolone—asthma	4.8e-05	0.000194	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisolone—asthma	4.79e-05	0.000194	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Methylprednisolone—asthma	4.78e-05	0.000193	CcSEcCtD
Dabigatran etexilate—Fatigue—Prednisone—asthma	4.77e-05	0.000193	CcSEcCtD
Dabigatran etexilate—Headache—Prednisolone—asthma	4.77e-05	0.000193	CcSEcCtD
Dabigatran etexilate—Constipation—Prednisone—asthma	4.73e-05	0.000191	CcSEcCtD
Dabigatran etexilate—Vomiting—Hydrocortisone—asthma	4.73e-05	0.000191	CcSEcCtD
Dabigatran etexilate—Rash—Hydrocortisone—asthma	4.69e-05	0.00019	CcSEcCtD
Dabigatran etexilate—Dermatitis—Hydrocortisone—asthma	4.68e-05	0.000189	CcSEcCtD
Dabigatran etexilate—Headache—Hydrocortisone—asthma	4.66e-05	0.000188	CcSEcCtD
Dabigatran etexilate—Dizziness—Triamcinolone—asthma	4.63e-05	0.000187	CcSEcCtD
Dabigatran etexilate—Dizziness—Methylprednisolone—asthma	4.62e-05	0.000187	CcSEcCtD
Dabigatran etexilate—Asthenia—Betamethasone—asthma	4.56e-05	0.000184	CcSEcCtD
Dabigatran etexilate—Asthenia—Dexamethasone—asthma	4.56e-05	0.000184	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Prednisone—asthma	4.52e-05	0.000183	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisolone—asthma	4.52e-05	0.000183	CcSEcCtD
Dabigatran etexilate—Pruritus—Betamethasone—asthma	4.49e-05	0.000182	CcSEcCtD
Dabigatran etexilate—Pruritus—Dexamethasone—asthma	4.49e-05	0.000182	CcSEcCtD
Dabigatran etexilate—Vomiting—Triamcinolone—asthma	4.45e-05	0.00018	CcSEcCtD
Dabigatran etexilate—Vomiting—Methylprednisolone—asthma	4.44e-05	0.00018	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—CAT—asthma	4.44e-05	0.00047	CbGpPWpGaD
Dabigatran etexilate—Nausea—Hydrocortisone—asthma	4.41e-05	0.000179	CcSEcCtD
Dabigatran etexilate—Rash—Triamcinolone—asthma	4.41e-05	0.000178	CcSEcCtD
Dabigatran etexilate—Dermatitis—Triamcinolone—asthma	4.41e-05	0.000178	CcSEcCtD
Dabigatran etexilate—Rash—Methylprednisolone—asthma	4.4e-05	0.000178	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methylprednisolone—asthma	4.4e-05	0.000178	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisone—asthma	4.39e-05	0.000178	CcSEcCtD
Dabigatran etexilate—Headache—Triamcinolone—asthma	4.38e-05	0.000177	CcSEcCtD
Dabigatran etexilate—F2—Signaling Pathways—CCR8—asthma	4.38e-05	0.000464	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TACR2—asthma	4.38e-05	0.000464	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	4.37e-05	0.000463	CbGpPWpGaD
Dabigatran etexilate—Headache—Methylprednisolone—asthma	4.37e-05	0.000177	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Prednisone—asthma	4.37e-05	0.000177	CcSEcCtD
Dabigatran etexilate—F2—GPCR downstream signaling—IL5—asthma	4.36e-05	0.000462	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—VEGFA—asthma	4.35e-05	0.00046	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Dexamethasone—asthma	4.34e-05	0.000176	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Betamethasone—asthma	4.34e-05	0.000176	CcSEcCtD
Dabigatran etexilate—F2—Hemostasis—PDGFB—asthma	4.34e-05	0.00046	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EDNRB—asthma	4.3e-05	0.000456	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL17—asthma	4.3e-05	0.000455	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—NPS—asthma	4.26e-05	0.000451	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TAC1—asthma	4.26e-05	0.000451	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC26A4—asthma	4.25e-05	0.00045	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCL8—asthma	4.24e-05	0.000449	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—TGFB1—asthma	4.21e-05	0.000446	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PLAU—asthma	4.21e-05	0.000446	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CDK2—asthma	4.21e-05	0.000446	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—BDKRB2—asthma	4.21e-05	0.000446	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Dexamethasone—asthma	4.2e-05	0.00017	CcSEcCtD
Dabigatran etexilate—Dizziness—Betamethasone—asthma	4.2e-05	0.00017	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—PLA2G4A—asthma	4.19e-05	0.000444	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GSTM1—asthma	4.19e-05	0.000444	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCR3—asthma	4.18e-05	0.000442	CbGpPWpGaD
Dabigatran etexilate—Nausea—Triamcinolone—asthma	4.16e-05	0.000168	CcSEcCtD
Dabigatran etexilate—Nausea—Methylprednisolone—asthma	4.15e-05	0.000168	CcSEcCtD
Dabigatran etexilate—UGT1A9—Metabolism—ALDH7A1—asthma	4.14e-05	0.000439	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Prednisone—asthma	4.07e-05	0.000165	CcSEcCtD
Dabigatran etexilate—F2—GPCR downstream signaling—ADCY2—asthma	4.07e-05	0.000431	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—asthma	4.06e-05	0.00043	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IL3—asthma	4.06e-05	0.00043	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	4.05e-05	0.000429	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL2—asthma	4.05e-05	0.000429	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALOX15—asthma	4.05e-05	0.000429	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALOX5AP—asthma	4.05e-05	0.000429	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Dexamethasone—asthma	4.04e-05	0.000163	CcSEcCtD
Dabigatran etexilate—Vomiting—Betamethasone—asthma	4.04e-05	0.000163	CcSEcCtD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	4.01e-05	0.000424	CbGpPWpGaD
Dabigatran etexilate—Rash—Dexamethasone—asthma	4e-05	0.000162	CcSEcCtD
Dabigatran etexilate—Rash—Betamethasone—asthma	4e-05	0.000162	CcSEcCtD
Dabigatran etexilate—Dermatitis—Dexamethasone—asthma	4e-05	0.000162	CcSEcCtD
Dabigatran etexilate—Dermatitis—Betamethasone—asthma	4e-05	0.000162	CcSEcCtD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	4e-05	0.000423	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TGFB1—asthma	3.99e-05	0.000422	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—POMC—asthma	3.99e-05	0.000422	CbGpPWpGaD
Dabigatran etexilate—Headache—Betamethasone—asthma	3.98e-05	0.000161	CcSEcCtD
Dabigatran etexilate—Headache—Dexamethasone—asthma	3.98e-05	0.000161	CcSEcCtD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—asthma	3.97e-05	0.000421	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ARG2—asthma	3.97e-05	0.00042	CbGpPWpGaD
Dabigatran etexilate—Asthenia—Prednisone—asthma	3.97e-05	0.00016	CcSEcCtD
Dabigatran etexilate—F2—Signaling by GPCR—IL5—asthma	3.96e-05	0.000419	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—FN1—asthma	3.91e-05	0.000415	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Prednisone—asthma	3.91e-05	0.000158	CcSEcCtD
Dabigatran etexilate—F2—GPCR ligand binding—CCL2—asthma	3.9e-05	0.000413	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ATP4A—asthma	3.89e-05	0.000412	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC30A8—asthma	3.89e-05	0.000412	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS2—asthma	3.87e-05	0.00041	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CHAT—asthma	3.86e-05	0.000409	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPP2CA—asthma	3.86e-05	0.000408	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDE4A—asthma	3.83e-05	0.000406	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KIF3A—asthma	3.83e-05	0.000406	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—KNG1—asthma	3.83e-05	0.000405	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	3.82e-05	0.000405	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—BDKRB2—asthma	3.82e-05	0.000405	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AGTR1—asthma	3.8e-05	0.000403	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Prednisone—asthma	3.78e-05	0.000153	CcSEcCtD
Dabigatran etexilate—Nausea—Betamethasone—asthma	3.77e-05	0.000153	CcSEcCtD
Dabigatran etexilate—Nausea—Dexamethasone—asthma	3.77e-05	0.000153	CcSEcCtD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL10—asthma	3.72e-05	0.000394	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADCY2—asthma	3.7e-05	0.000391	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL3—asthma	3.68e-05	0.00039	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Prednisone—asthma	3.66e-05	0.000148	CcSEcCtD
Dabigatran etexilate—F2—GPCR downstream signaling—ADRB2—asthma	3.61e-05	0.000382	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CYSLTR1—asthma	3.59e-05	0.00038	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Prednisone—asthma	3.52e-05	0.000142	CcSEcCtD
Dabigatran etexilate—Rash—Prednisone—asthma	3.49e-05	0.000141	CcSEcCtD
Dabigatran etexilate—Dermatitis—Prednisone—asthma	3.48e-05	0.000141	CcSEcCtD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	3.48e-05	0.000369	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—KNG1—asthma	3.48e-05	0.000368	CbGpPWpGaD
Dabigatran etexilate—Headache—Prednisone—asthma	3.46e-05	0.00014	CcSEcCtD
Dabigatran etexilate—F2—Signaling Pathways—CCL11—asthma	3.46e-05	0.000367	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—C5AR1—asthma	3.46e-05	0.000367	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—UTS2—asthma	3.46e-05	0.000367	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CMA1—asthma	3.46e-05	0.000367	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VIP—asthma	3.46e-05	0.000367	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AGTR1—asthma	3.45e-05	0.000366	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALOX5—asthma	3.44e-05	0.000365	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—VEGFA—asthma	3.44e-05	0.000364	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ITPR1—asthma	3.41e-05	0.000362	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL10—asthma	3.38e-05	0.000358	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR4—asthma	3.32e-05	0.000352	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALOX5AP—asthma	3.29e-05	0.000348	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALOX15—asthma	3.29e-05	0.000348	CbGpPWpGaD
Dabigatran etexilate—Nausea—Prednisone—asthma	3.28e-05	0.000133	CcSEcCtD
Dabigatran etexilate—UGT2B7—Metabolism—CARM1—asthma	3.28e-05	0.000348	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRB2—asthma	3.28e-05	0.000347	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—LEP—asthma	3.27e-05	0.000346	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPINE1—asthma	3.26e-05	0.000345	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—STAT6—asthma	3.26e-05	0.000345	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—ALB—asthma	3.25e-05	0.000344	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—DCN—asthma	3.24e-05	0.000343	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—EDN1—asthma	3.23e-05	0.000342	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCL5—asthma	3.2e-05	0.000339	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL2RB—asthma	3.2e-05	0.000338	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	3.19e-05	0.000338	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDE4D—asthma	3.17e-05	0.000335	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TGFB1—asthma	3.16e-05	0.000334	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CSF2—asthma	3.15e-05	0.000334	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALDH2—asthma	3.15e-05	0.000333	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—RHOA—asthma	3.14e-05	0.000333	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CHAT—asthma	3.14e-05	0.000332	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS3—asthma	3.11e-05	0.000329	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ITPR1—asthma	3.1e-05	0.000328	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDE4B—asthma	3.09e-05	0.000327	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TACR1—asthma	3.09e-05	0.000327	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—C5—asthma	3.09e-05	0.000327	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL8—asthma	3.08e-05	0.000327	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	3.07e-05	0.000325	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTT1—asthma	2.99e-05	0.000317	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—POMC—asthma	2.96e-05	0.000314	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—asthma	2.95e-05	0.000312	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EDN1—asthma	2.93e-05	0.00031	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL5—asthma	2.91e-05	0.000308	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PLA2G4A—asthma	2.9e-05	0.000307	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCR5—asthma	2.88e-05	0.000305	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CSF2—asthma	2.86e-05	0.000303	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IL2RA—asthma	2.84e-05	0.000301	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR3—asthma	2.82e-05	0.000299	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—C3—asthma	2.82e-05	0.000298	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—POMC—asthma	2.81e-05	0.000297	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALOX5—asthma	2.8e-05	0.000296	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LTC4S—asthma	2.77e-05	0.000294	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NPY—asthma	2.75e-05	0.000291	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CCL2—asthma	2.74e-05	0.000291	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ALB—asthma	2.7e-05	0.000286	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CARM1—asthma	2.67e-05	0.000283	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PPP2CA—asthma	2.67e-05	0.000282	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGTR2—asthma	2.65e-05	0.000281	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IL2—asthma	2.64e-05	0.000279	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—DCN—asthma	2.63e-05	0.000279	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCR5—asthma	2.62e-05	0.000277	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—CARM1—asthma	2.61e-05	0.000277	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NOS3—asthma	2.58e-05	0.000273	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL2RA—asthma	2.58e-05	0.000273	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—C3—asthma	2.56e-05	0.000271	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALDH2—asthma	2.56e-05	0.000271	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EDNRB—asthma	2.54e-05	0.000269	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TAC1—asthma	2.52e-05	0.000266	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NPS—asthma	2.52e-05	0.000266	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NQO1—asthma	2.49e-05	0.000264	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCR3—asthma	2.47e-05	0.000261	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—POMC—asthma	2.46e-05	0.000261	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADCY2—asthma	2.44e-05	0.000258	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTT1—asthma	2.43e-05	0.000258	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LTA4H—asthma	2.4e-05	0.000255	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CYBA—asthma	2.39e-05	0.000253	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—asthma	2.36e-05	0.00025	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PARP1—asthma	2.34e-05	0.000248	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL5—asthma	2.34e-05	0.000248	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	2.27e-05	0.00024	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BDKRB2—asthma	2.26e-05	0.000239	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—POMC—asthma	2.25e-05	0.000239	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ALB—asthma	2.24e-05	0.000238	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—asthma	2.24e-05	0.000237	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADCY2—asthma	2.18e-05	0.000231	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL3—asthma	2.18e-05	0.00023	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CXCL8—asthma	2.17e-05	0.00023	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	2.16e-05	0.000228	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ARG1—asthma	2.1e-05	0.000222	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTP1—asthma	2.08e-05	0.00022	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTEN—asthma	2.06e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—asthma	2.06e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KNG1—asthma	2.05e-05	0.000217	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMOX1—asthma	2.05e-05	0.000217	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—POMC—asthma	2.05e-05	0.000217	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ITPR1—asthma	2.04e-05	0.000216	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGTR1—asthma	2.04e-05	0.000216	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NQO1—asthma	2.02e-05	0.000214	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CAT—asthma	2.02e-05	0.000214	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—asthma	2e-05	0.000212	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6R—asthma	2e-05	0.000211	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL10—asthma	1.99e-05	0.000211	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—RHOA—asthma	1.99e-05	0.00021	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADCY2—asthma	1.98e-05	0.00021	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.96e-05	0.000208	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NTRK1—asthma	1.96e-05	0.000207	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	1.94e-05	0.000205	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB2—asthma	1.94e-05	0.000205	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PLA2G4A—asthma	1.91e-05	0.000202	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTM1—asthma	1.91e-05	0.000202	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALDH7A1—asthma	1.9e-05	0.000201	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	1.88e-05	0.000199	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ITPR1—asthma	1.83e-05	0.000194	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ARG2—asthma	1.82e-05	0.000193	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—RHOA—asthma	1.8e-05	0.000191	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPP2CA—asthma	1.76e-05	0.000186	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CD86—asthma	1.74e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL8—asthma	1.74e-05	0.000185	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EDN1—asthma	1.73e-05	0.000183	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL5—asthma	1.72e-05	0.000182	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—asthma	1.71e-05	0.000181	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLA2G4A—asthma	1.71e-05	0.000181	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.7e-05	0.00018	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CSF2—asthma	1.69e-05	0.000179	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTP1—asthma	1.69e-05	0.000179	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IL2—asthma	1.67e-05	0.000176	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMOX1—asthma	1.66e-05	0.000176	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ITPR1—asthma	1.66e-05	0.000176	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SMAD3—asthma	1.65e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CAT—asthma	1.64e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	1.63e-05	0.000173	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL8—asthma	1.58e-05	0.000168	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PPP2CA—asthma	1.58e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.56e-05	0.000165	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PLA2G4A—asthma	1.55e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTM1—asthma	1.55e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR5—asthma	1.55e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.53e-05	0.000162	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL2RA—asthma	1.52e-05	0.000161	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL2—asthma	1.51e-05	0.00016	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—C3—asthma	1.51e-05	0.00016	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALOX5AP—asthma	1.51e-05	0.00016	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALOX15—asthma	1.51e-05	0.00016	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDGFB—asthma	1.47e-05	0.000156	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.46e-05	0.000154	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CHAT—asthma	1.44e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPP2CA—asthma	1.43e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LEP—asthma	1.41e-05	0.000149	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—POMC—asthma	1.35e-05	0.000143	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FN1—asthma	1.33e-05	0.000141	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALOX5—asthma	1.28e-05	0.000136	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—asthma	1.23e-05	0.00013	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CARM1—asthma	1.22e-05	0.00013	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—POMC—asthma	1.21e-05	0.000128	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DCN—asthma	1.21e-05	0.000128	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—asthma	1.18e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6R—asthma	1.18e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NOS3—asthma	1.18e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALDH2—asthma	1.17e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EGFR—asthma	1.16e-05	0.000123	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTT1—asthma	1.12e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SERPINE1—asthma	1.1e-05	0.000117	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—POMC—asthma	1.1e-05	0.000116	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—asthma	1.08e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RHOA—asthma	1.07e-05	0.000113	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOS3—asthma	1.05e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—asthma	9.99e-06	0.000106	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—asthma	9.78e-06	0.000104	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NOS3—asthma	9.56e-06	0.000101	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTEN—asthma	9.38e-06	9.93e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL8—asthma	9.35e-06	9.9e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NQO1—asthma	9.28e-06	9.83e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADCY2—asthma	9.08e-06	9.62e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL2—asthma	8.94e-06	9.46e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—asthma	8.89e-06	9.42e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—asthma	8.74e-06	9.25e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—asthma	8.46e-06	8.96e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTEN—asthma	8.41e-06	8.9e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTP1—asthma	7.74e-06	8.19e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMOX1—asthma	7.63e-06	8.08e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTEN—asthma	7.62e-06	8.07e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ITPR1—asthma	7.61e-06	8.06e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—asthma	7.6e-06	8.04e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CAT—asthma	7.53e-06	7.97e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—STAT3—asthma	7.52e-06	7.96e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTM1—asthma	7.11e-06	7.53e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PLA2G4A—asthma	7.11e-06	7.53e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—asthma	6.97e-06	7.38e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EGFR—asthma	6.84e-06	7.24e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPP2CA—asthma	6.55e-06	6.94e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—asthma	5.25e-06	5.56e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—POMC—asthma	5.03e-06	5.32e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—asthma	4.58e-06	4.85e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NOS3—asthma	4.38e-06	4.64e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—asthma	4.01e-06	4.25e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTEN—asthma	3.5e-06	3.7e-05	CbGpPWpGaD
